388 related articles for article (PubMed ID: 25180064)
1. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs.
Boyd AL; Campbell CJ; Hopkins CI; Fiebig-Comyn A; Russell J; Ulemek J; Foley R; Leber B; Xenocostas A; Collins TJ; Bhatia M
J Exp Med; 2014 Sep; 211(10):1925-35. PubMed ID: 25180064
[TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
[TBL] [Abstract][Full Text] [Related]
3. Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.
Grenier JMP; Testut C; Fauriat C; Mancini SJC; Aurrand-Lions M
Front Immunol; 2021; 12():756231. PubMed ID: 34867994
[TBL] [Abstract][Full Text] [Related]
4. Age-related differences in the bone marrow stem cell niche generate specialized microenvironments for the distinct regulation of normal hematopoietic and leukemia stem cells.
Lee GY; Jeong SY; Lee HR; Oh IH
Sci Rep; 2019 Jan; 9(1):1007. PubMed ID: 30700727
[TBL] [Abstract][Full Text] [Related]
5. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
Marchand T; Pinho S
Front Immunol; 2021; 12():775128. PubMed ID: 34721441
[TBL] [Abstract][Full Text] [Related]
6. Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.
García-García A; Klein T; Born G; Hilpert M; Scherberich A; Lengerke C; Skoda RC; Bourgine PE; Martin I
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34580200
[TBL] [Abstract][Full Text] [Related]
7. Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.
Glait-Santar C; Desmond R; Feng X; Bat T; Chen J; Heuston E; Mizukawa B; Mulloy JC; Bodine DM; Larochelle A; Dunbar CE
Stem Cells; 2015 Dec; 33(12):3635-42. PubMed ID: 26388434
[TBL] [Abstract][Full Text] [Related]
8. Normal and leukemic stem cell niches: insights and therapeutic opportunities.
Schepers K; Campbell TB; Passegué E
Cell Stem Cell; 2015 Mar; 16(3):254-67. PubMed ID: 25748932
[TBL] [Abstract][Full Text] [Related]
9. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.
Balandrán JC; Dávila-Velderrain J; Sandoval-Cabrera A; Zamora-Herrera G; Terán-Cerqueda V; García-Stivalet LA; Limón-Flores JA; Armenta-Castro E; Rodríguez-Martínez A; Leon-Chavez BA; Vallejo-Ruiz V; Hassane DC; Pérez-Tapia SM; Ortiz-Navarrete V; Guzman ML; Pelayo R
Front Immunol; 2021; 12():746492. PubMed ID: 34737747
[TBL] [Abstract][Full Text] [Related]
10. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
[TBL] [Abstract][Full Text] [Related]
11. Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment.
Selleri C; Montuori N; Salvati A; Serio B; Pesapane A; Ricci P; Gorrasi A; Li Santi A; Hoyer-Hansen G; Ragno P
Oncotarget; 2016 Sep; 7(37):60206-60217. PubMed ID: 27517491
[TBL] [Abstract][Full Text] [Related]
12. Differential niche and Wnt requirements during acute myeloid leukemia progression.
Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
[TBL] [Abstract][Full Text] [Related]
13. Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches.
Krenn PW; Koschmieder S; Fässler R
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24326-24335. PubMed ID: 32929022
[TBL] [Abstract][Full Text] [Related]
14. Role of Microenvironment in Resistance to Therapy in AML.
Tabe Y; Konopleva M
Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
[TBL] [Abstract][Full Text] [Related]
15. Leukemia Stem Cells Microenvironment.
Tabe Y; Konopleva M
Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827
[TBL] [Abstract][Full Text] [Related]
16. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
17. Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
Cui P; Zhang Y; Cui M; Li Z; Ma G; Wang R; Wang N; Huang S; Gao J
Leuk Res; 2018 Feb; 65():49-54. PubMed ID: 29306107
[TBL] [Abstract][Full Text] [Related]
18. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
19. Regulation of hematopoietic and leukemic stem cells by the immune system.
Riether C; Schürch CM; Ochsenbein AF
Cell Death Differ; 2015 Feb; 22(2):187-98. PubMed ID: 24992931
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities.
O'Reilly E; Zeinabad HA; Szegezdi E
Blood Rev; 2021 Nov; 50():100850. PubMed ID: 34049731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]